1 Min Read
NEW YORK, March 28 (Reuters) - Repros Therapeutics Inc : * Jumps 75.3 to $16 in premarket after testosterone drug hits main goals of study
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.